RTM program · Medical oncology

Oncology symptom monitoring

Electronic symptom monitoring during systemic therapy has survival evidence behind it and no clean code.

Randomized evidence supports electronic symptom monitoring during systemic therapy improving quality of life, reducing emergency visits, and in at least one trial extending survival. It is among the better-evidenced digital interventions in oncology. The billing story is genuinely unsettled: symptom reporting is not physiologic monitoring, and the RTM body-system categories were not written with oncology in mind. Programs are commonly funded through value-based arrangements, institutional quality budgets, or sponsorship rather than fee-for-service. We would rather tell you that than sell you a code that denies.

Oncology symptom monitoring · observed transmission profile Representative, not best case

Day 1Day 15Day 30

Transmitted days 0 / 30

Device supply code —

Start this program Model the economics

Signal stack

What gets measured, from where, and why it earns its place

Every source is tagged at ingest as billable or context-only. Context-only data is clinically valuable and never enters a device-supply line.

Structured symptom reporting

PRO-CTCAE derived items, daily or every other day

Severity-graded items selected for the regimen, not a generic checklist. Twelve items maximum or completion collapses.

Weight

Connected scale

Unintentional loss is a treatment-modification signal and a nutrition-referral trigger.

Temperature

Connected thermometer

Neutropenic fever pathway. This one has to have a tested escalation route or do not enable it.

Functional status

Weekly short form or passive step count

Performance status is the variable every treatment decision references and almost nobody measures between visits.

Escalation design

Thresholds, and who has to do something about them

Red marks a same-day or immediate pathway. Amber marks a review within the stated window. Each one is assigned to a named clinician with a response clock, not to a queue.

Temperature >= 38.3 C, or >= 38.0 C sustained one hour

ResponseImmediate neutropenic fever protocol

Any grade 3 symptom report

ResponseSame-day clinical contact

Two grade 2 symptoms rising over 72 hours

Response48-hour review

Weight loss > 5% in 30 days

ResponseNutrition referral, treatment review

What we will not oversell

Do not assume an RTM code fits. Confirm the coverage path with your compliance team and your MAC before building a revenue model on this program. Gathermed will run it either way; we will not pretend the reimbursement is settled.

Program operation

How the month actually runs

Regimen-specific item set built at protocol level, not per patient.

Escalation pathway tested before enrollment. A febrile neutropenia alert with no route is a liability.

Nurse triage queue with response clocks and a documented disposition per alert.

Symptom trajectory attached to each treatment decision in the record.

Reconcile funding path monthly. If a code is being billed, the documentation has to support that specific code and not the idea of monitoring.

Code path · CY2026

What this program can bill

Rates are national non-facility averages, rounded, for orientation. They vary by locality and payer. Verify against your fee schedule before you model revenue on them.

Code	What it covers	National avg	Cadence
98975	Setup and patient education One-time setup and education on use of the monitoring equipment.	$21.71	once per episode
98978	Device supply, cognitive behavioral therapy, 16-30 days Device supply for cognitive behavioral therapy monitoring, 16 or more days of data in 30.	$39.75	per 30 days
98986new 2026	Device supply, cognitive behavioral therapy, 2-15 days New for 2026. Short-duration CBT device supply. Mutually exclusive with 98978.	$39.75	per 30 days
98980	Treatment management, first 20 min 20 minutes of QHP management time with at least one interactive communication.	$53.77	per calendar month
98979new 2026	Treatment management, first 10 min New for 2026. 10 to 19 minutes of management time with at least one interactive communication. Mutually exclusive with 98980.	$26.05	per calendar month
98981	Treatment management, each additional 20 min Add-on to 98980. Reported per additional 20 minutes in the month.	$41.8	per additional 20 min

Diagnosis anchors

ICD-10-CM	Description
Z51.11	Encounter for antineoplastic chemotherapy
C50.911	Malignant neoplasm of unspecified site of right female breast
R11.2	Nausea with vomiting, unspecified

Illustrative anchors only. Code to the documented clinical picture, not to a list on a vendor website.

The rules that break programs

One billing clinician per 30-day episode. RPM and RTM are not additive in the same calendar month. Duration codes are mutually exclusive. Management time requires at least one real-time interactive communication. Medical necessity precedes enrollment.

Full rule set and calculator

Sponsor view

If you are a manufacturer looking at this condition

Strong sponsored case with an unusually clear scientific rationale. Tolerability data collected prospectively at daily resolution is materially better than the retrospective adverse-event capture in most registries. A sponsor gets dose-modification patterns, time-to-toxicity, symptom-driven discontinuation, and supportive-care utilization. Relevant to oral oncolytics, antibody-drug conjugates, and any program where real-world tolerability drives adoption.

Read this before you fund anything

Sponsor-funded monitoring that produces billable revenue for prescribers is remuneration to referral sources under the federal Anti-Kickback Statute. The structures that survive scrutiny keep the sponsor's data interest and the provider's billing interest completely separate. The three structures we will build, and the one we will not.

Questions

Oncology symptom monitoring monitoring, answered directly

Is there a CPT code for oncology ePRO monitoring?

There is no code written for it. Some programs report RTM codes where the monitoring genuinely fits a listed body system and the documentation supports it. Many are funded outside fee-for-service. Get a coverage determination before you model revenue.

Does symptom monitoring really improve survival?

One randomized trial reported a survival difference, and multiple trials reported quality-of-life and utilization benefits. It is among the stronger digital health evidence bases, and it is one trial for the survival endpoint specifically.

Adjacent programs

Conditions that travel with this one

Comorbidity is the norm. One episode, one billing clinician, one device-supply line per 30 days, even when the patient has four diagnoses.

Concussion and mild traumatic brain injuryRecovery is a trajectory across several independent systems, and none of them is a single score. RTM Neurology, sports medicine, concussion clinic, physical medicine 98975 98978 98986 Depression and anxiety treatment monitoringMeasurement-based care works and almost nobody does it. The measurement is the intervention. RTM Psychiatry, behavioral health, primary care 98975 98978 98986

Start this program All 18 conditions